NCT03710603 2026-02-10PerseusEuropean Myeloma Network B.V.Phase 3 Active not recruiting709 enrolled 17 charts 2 FDA
NCT03180736 2025-12-19EMN14European Myeloma Network B.V.Phase 3 Completed304 enrolled 19 charts 2 FDA
NCT02541383 2025-04-13CassiopeiaIntergroupe Francophone du MyelomePhase 3 Completed1,085 enrolled 22 charts 2 FDA
NCT00716976 2023-11-09Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other MalignancyChildren's Oncology GroupPhase 3 Completed131 enrolled 18 charts 2 FDA
NCT00372593 2021-03-24Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid LeukemiaChildren's Oncology GroupPhase 3 Completed1,070 enrolled 18 charts 3 FDA